ÉúÎïͨ±¨µÀ À´×ÔÇ廪´óѧ¡¢·¨¹ú°Í˹µÂÑо¿ËùµÄÑо¿ÈËԱ֤ʵ£¬µ°°×ÖÊSUMO»¯ÐÞÊÎ(SUMOylation)Êǵ÷½ÚÐÔTϸ°û£¨Treg£©À©ÔöºÍ·¢»Ó¹¦ÄܵıØÒªÌõ¼þ¡£ÕâÒ»Ñо¿·¢ÏÖ·¢²¼ÔÚ4ÔÂ17Èյġ¶Cell Reports¡·ÔÓÖ¾ÉÏ¡£

Ç廪´óѧҽѧԺµÄ¶­³¿£¨Chen Dong£©½ÌÊÚÊÇÕâÆªÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£¶­½ÌÊÚÊÇÈ«ÇòÃâÒßѧ½ç×î¶¥¼âµÄѧÕßÖ®Ò»¡£ÆäÁìµ¼µÄÍŶÓÔÚ·¢ÏÖÖØÒªÃâÒßÄÍÊܵ÷½Ú·Ö×Ó·½Ãæ×ö³öÁËÖØÒª¹±Ïס£2009Äê±»ÃÀ¹úÃâÒßѧѧ»áÊÚÓèÈ¡µÃ½Ü³ö³É¾ÍµÄÇàÄêÃâÒßѧ¼Ò½±£¬ÒÑÔÚ¹ú¼ÊÒ»Á÷ѧÊõÆÚ¿¯·¢±íÂÛÎļ°×¨Öø100¶àƪ¡£

Á¢¼´Ë÷È¡RBp siRNAÎÄ¿âµÄÏêϸ×ÊÁÏ

ÃâÒßϵͳ¿ÉÒÔ±£»¤ËÞÖ÷ÃâÊÜ´óÁ¿µÄ²¡Ô­vwinµÂÓ®µÄÇÖº¦£¬È»¶ø£¬¿ØÖÆÒì³£»ò¹ý¶ÈÃâÒßÓ¦´ð¿É½«¶Ô»úÌåÔì³ÉÉ˺¦¡£ÓÐÖ¤¾ÝÏÔʾ,ÓÐÒ»ÖÖTϸ°ûÑÇȺ¿ÉÒÔÓÐЧµØÒÖÖÆ²¡¶¾²¡ÀíѧºÍÉúÀíѧÃâÒßÓ¦´ð£¬´Ó¶øÓÐÖúÓÚά»¤×ÔÉíÃâÒßÄÍÊܺÍÃâÒßÓ¦´ðµÄ¶¯Ì¬Æ½ºâ,³ÆÎªTregϸ°û¡£Tregϸ°ûÄܹ»ÒÖÖÆ¹ý¶ÈµÄÃâÒß·´Ó¦£¬¶ÔÓÚÒÖÖÆ×ÔÉíÃâÒßÐÔ¼²²¡£¬Î¬³ÖÕû¸ö»úÌåµÄÃâÒßÎÈ̬ÒÔ¼°ÔÚ¸ÐȾ״̬ϵ÷¿ØÃâÒß·´Ó¦Æð×ŷdz£ÖØÒªµÄ×÷Óá£Tregϸ°û¹¦ÄÜʧµ÷£¬»áµ¼ÖÂÑÏÖØµÄ×ÔÉíÃâÒß²¡ÒÔ¼°Ñ×ÐÔ¼²²¡£¬°üÀ¨IÐÍÌÇÄò²¡¡¢·çʪÐԹؽÚÑס¢¶àÄÜÓ²»¯Ö¢ÒÔ¼°ÏµÍ³ÐÔºì°ßÀÇ´¯µÈ¡£µ«µ±Ç°¶ÔÓÚTregϸ°ûÀ©ÔöºÍ·¢»Ó¹¦ÄܵÄDZÔÚ·Ö×Ó»úÖÆÈÔ²»ÊǺÜÇå³þ¡£

SUMOÊǽüÄêÀ´±»·¢ÏÖµÄÊýÖÖÓë·ºËØ£¨ubiquitin£©ÏàÀàËÆµÄµ°°×ÖÊÖ®Ò»£¬Ëü¿É¾­ÓÉÀàËÆµÄ·ºËØ»¯¹ý³ÌÓÚÄ¿±êµ°°×ÖÊÉÏÌØ¶¨µÄÀµ°±ËáÖ§Á´Ðγɹ²¼Û¼ü¶øÐÞÊÎÄ¿±êµ°°×£¬Õâ¸ö¹ý³Ì³ÆÎªSUMO»¯ÐÞÊΡ£SUMO»¯ÐÞÊζÔÓڰе°°×µÄ¹¦ÄÜ£¬Èçµ°°×ÖʵÄÎȶ¨ÐÔ¡¢ÑÇϸ°û¶¨Î»¡¢ÐźÅתµ¼¡¢»ùÒòת¼µ÷¿ØµÈ¾ßÓÐÖØÒªµÄµ÷½Ú¹¦ÄÜ¡£Ubc9ÊÇĿǰ·¢ÏÖµÄSUMO»¯Í¾¾¶ÖÐΨһµÄE2½áºÏø,ÔÚµ°°×SUMO»¯µÄ¹ý³ÌÖÐÆðµ½ÖØÒª×÷Óá£

ÔÚÕâÆªÎÄÕÂÖУ¬Ñо¿ÈËԱ֤ʵѡÔñÐÔɾ³ýTregϸ°ûϵÖеÄUbc9¿Éµ¼ÖÂÓëFoxp3Í»±äСÊóÏàËÆµÄÖÂÃüÐÔÔç·¢×ÔÉíÃâÒß¡£Ubc9ȱÏÝTregϸ°ûÏÔʾTCRÇý¶¯ÎÈ̬ÔöÖ³³öÏÖÑÏÖØÈ±ÏÝ£¬°éËæ¼¤»îÊÜËð¼°ÒÖÖÆ¹¦ÄÜÔâµ½ÆÆ»µ¡£ÖØÒªµØÊÇ£¬ËûÃÇ֤ʵTCR½áºÏ¿É´Ù½øTCRÐźÅÏÂÓÎTregϸ°û¹¦ÄÜÒ»¸öÖÁ¹ØÖØÒªµÄµ÷¿ØÒò×ÓIRF4·¢ÉúSUMO»¯ÐÞÊΣ¬µ÷¿ØÁËËüÔÚTregϸ°ûÖеÄÎȶ¨ÐÔ¡£

ÕâЩÑо¿Êý¾Ý֤ʵÁËSUMO»¯ÐÞÊÎÔÚTregϸ°ûµÄÀ©ÔöÓ빦ÄÜÖÐÆð×ÅÖÁ¹ØÖØÒªµÄ×÷Óá£

2015Äê11Ô£¬À´×ÔÖÐɽ´óѧ¡¢Ò®Â³´óѧµÄÑо¿ÈËԱ֤ʵ£¬ÔÚÖ¬·¾Ï¸°ûÖÐSENp1½éµ¼µÄNEMOÈ¥SUMO»¯£¨deSUMOylation£©ÏÞÖÆÁËÑ×Ö¢·´Ó¦¼°IÐÍÌÇÄò²¡½øÕ¹¡£Ñо¿ÂÛÎÄ·¢±íÔÚNature CommunicationsÔÓÖ¾ÉÏ£¨ÖÐɽ´óѧ****½ÌÊÚNature×Ó¿¯·¢±íÌÇÄò²¡Ð³ɹû £©¡£

2015Äê9Ô£¬ÖÐɽ´óѧÉúÃü¿ÆÑ§Ñ§Ôº¡¢ÏÃÃÅ´óѧºÍÃÀ¹úLa Jolla¹ýÃôÓëÃâÒßÑо¿ËùµÄÑо¿ÈËԱ֤ʵ£¬Tϸ°ûÊÜÌ壨TCR£©ÓÕµ¼µÄpKC-¦È¼¤Ã¸SUMO»¯ÐÞÊοØÖÆÁËTϸ°ûÍ»´¥Ðγɼ°Tϸ°û¼¤»î¡£ÕâÒ»Ñо¿·¢ÏÖ·¢²¼ÔÚNature ImmunologyÔÓÖ¾ÉÏ£¨ÖÐɽ´óѧNature×Ó¿¯·¢±íÃâÒßÐÂÎÄÕ £©¡£

2015Äê3Ô£¬Å¦Ô¼´óѧºÍ¸çÂ×±ÈÑÇ´óѧµÄÑо¿ÈËÔ±½âÎöÁËSUMO»¯¿ØÖÆ»ùÒò±í´ïµÄ¾ßÌå»úÖÆ£¬²¢½«Ñо¿½á¹û·¢±íÔÚNature CommunicationsÔÓÖ¾ÉÏ¡£ËûÃÇÈÏΪ£¬ÕâÒ»»úÖÆ¿ÉÒÔ°ïÖúÈËÃǽøÒ»²½Àí½â°©Ö¢Öв»ÊÜ¿ØÖƵĻùÒò±í´ï£¨Nature×Ó¿¯£ºSUMO¿ØÖÆ×ªÂ¼Ê§»îµÄʱ»ú£©¡£

£¨ÉúÎïͨ£ººÎæÍ£©

ÉúÎïÍ¨ÍÆ¼öÔ­ÎÄÕªÒª£º

protein SUMOylation Is Required for Regulatory T Cell Expansion and Function

Foxp3-expressing regulatory T (Treg) cells are essential for immune tolerance; however, the molecular mechanisms underlying Treg cell expansion and function are still not well understood. SUMOylation is a protein post-translational modification characterized by covalent attachment of SUMO moieties to lysines. UBC9 is the only E2 conjugating enzyme involved in this process, and loss of UBC9 completely abolishes the SUMOylation pathway. Here, we report that selective deletion of Ubc9 within the Treg lineage results in fatal early-onset autoimmunity similar to Foxp3 mutant mice. Ubc9-deficient Treg cells exhibit severe defects in TCR-driven homeostatic proliferation, accompanied by impaired activation and compromised suppressor function. Importantly, TCR ligation enhanced SUMOylation of IRF4, a critical regulator of Treg cell function downstream of TCR signals, which regulates its stability in Treg cells. Our data thus have demonstrated an essential role of SUMOylation in the expansion and function of Treg cells.

×÷Õß¼ò½é£º

¶­³¿

µÂ¿ËÈøË¹´óѧMD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄ£¬Ñ×Ö¢ºÍ°©Ö¢Ñо¿ÖÐÐĵÄÖ÷ÈΣ¬¼°µÂ¿ËÈøË¹´óѧMD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄÃâÒßѧϵ½ÌÊÚ£¨ÖÕÉí£©¡£Ä¿Ç°ÊÜÆ¸ÎªÇ廪´óѧҽѧԺ½ÌÊÚ¼°¸±Ôº³¤¡£

¿ÆÑÐÒµ¼¨
µÂ¿ËÈøË¹´óѧMD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄ£¬Ñ×Ö¢ºÍ°©Ö¢Ñо¿ÖÐÐĵÄÖ÷ÈΣ¬¼°µÂ¿ËÈøË¹´óѧMD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄÃâÒßѧϵ½ÌÊÚ£¨ÖÕÉí£©¡£½ü20ÄêÀ´Ö÷ÒªÑо¿¹ÌÓÐÃâÒߺͻñµÃÐÔÃâÒߵĵ÷½Ú¡¢Ï¸°ûĤ·Ö×ÓÐźÅתµ¼¼°»ùÒò±í´ïµÄµ÷¿Ø»úÖÆ£¬Öصã̽ÌÖÕý³£ÃâÒßÓ¦´ðÒÔ¼°ÃâÒßµ÷½ÚÒì³£µ¼ÖµÄÃâÒßȱÏÝ¡¢×ÔÉíÃâÒßÐÔ¼²²¡ºÍ¹ýÃô·´Ó¦µÄ·Ö×Óµ÷¿Ø»úÖÆ¡£ÆäÁìµ¼µÄÍŶÓÔÚ·¢ÏÖÖØÒªÃâÒßÄÍÊܵ÷½Ú·Ö×Ó·½Ãæ×ö³öÁËÖØÒª¹±Ï×£¬ÌرðÊÇÔÚTh17ϸ°ûµÄ·Ö»¯¡¢µ÷½ÚºÍ¹¦ÄÜÑо¿·½Ãæ½øÐÐÁË´óÁ¿¿ª´´ÐԵŤ×÷, ÊǸÃÁìÓòµÄÑо¿È¨ÍþÖ®Ò»¡£Æä·¢ÏÖ¶ÔÈËÃÇÀí½âÑ×Ö¢¡¢×ÔÉíÃâÒßÐÔ¼²²¡ºÍ¹ýÃôÐÔ¼²²¡µÄ·¢²¡»úÖÆ£¬ÒÔ¼°Ì½Ë÷ÓÐЧµÄÖÎÁÆ·½·¨ÌṩÁ˺ܴóµÄ°ïÖú¡£ÒÑÔÚ¹ú¼ÊÒ»Á÷ѧÊõÆÚ¿¯·¢±íÂÛÎļ°×¨Öø100ÓàÆª£¬¹²»ñµÃ10¶àÏî×ÊÖú£¬ÆäÖÐNIH×ÊÖú6ÏĿǰÔÚÑÐ10Ïî¡£2009Äê±»ÃÀ¹úÃâÒßѧѧ»áÊÚÓèÈ¡µÃ½Ü³ö³É¾ÍµÄÇàÄêÃâÒßѧ¼Ò½±¡£Ä¿Ç°ÊÜÆ¸ÎªÇ廪´óѧҽѧԺ½ÌÊÚ¼°¸±Ôº³¤¡£